It has been demonstrated that PTEN and PHLPP2 are critical negative regulators of PI3K/Akt signaling, which prompted us to further examine whether dysregulation miR-93 alters the activity of PI3K/Akt signaling in glioma cells. Here, AKT1 is linked to central nervous system cancer.